OSL:AKBM • NO0010886625
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AKER BIOMARINE ASA (AKBM.OL).
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 277.2M 5.78% | 335.3M 20.96% | 199M -40.65% | 225.52M 13.33% | 260.17M 15.36% | 286.25M 10.02% | 619.85M 116.54% | 682.44M 10.10% | 750.08M 9.91% | |
| EBITDA YoY % growth | 73.5M 88.12% | 53.7M -26.94% | 44.8M -16.57% | 44.2M -1.34% | 62.9M 42.31% | 76.16M 21.08% | N/A | N/A | N/A | |
| EBIT YoY % growth | 22.1M 283.98% | 1.4M -93.67% | -3M -314.29% | 17M 666.67% | 37.23M 119.00% | 48.62M 30.59% | N/A | N/A | N/A | |
| Operating Margin | 7.97% | 0.42% | -1.51% | 7.54% | 14.31% | 16.99% | N/A | N/A | N/A | |
| EPS YoY % growth | 0.07 248.94% | -0.04 -157.14% | N/A 227.50% | 0.09 70.00% | 0.24 178.44% | 0.38 59.15% | N/A | N/A | N/A |
All data in USD
| Q4 / 25 | |
|---|---|
| EPS Q2Q % growth | 0.05 163.75% |
| Revenue Q2Q % growth | 61.88M 19.00% |
| EBITDA Q2Q % growth | 13.94M -71.02% |
| EBIT Q2Q % growth | 6.8M 2,166.67% |
All data in USD
9 analysts have analysed AKBM.OL and the average price target is 96.9 NOK. This implies a price decrease of -6.83% is expected in the next year compared to the current price of 104.
AKER BIOMARINE ASA (AKBM.OL) will report earnings on 2026-04-30.
The consensus EPS estimate for the next earnings of AKER BIOMARINE ASA (AKBM.OL) is 0.05 NOK and the consensus revenue estimate is 61.88M NOK.
The expected long term growth rate for AKER BIOMARINE ASA (AKBM.OL) is 2.27%.